ATM Activation by PARP Inhibitor Elongates Telomere

Case ID:
C13675
Disclosure Date:
5/28/2015
Description:

INVENTION NOVELTY

This invention is a new assay termed ADDIT (Addition of de novo initiated telomeres) that can rapidly identify effectors of telomere length, even if the regulators are essential genes and a method of regulating telomere length with a PARP inhibitor.

VALUE PROPOSITION

The researchers developed an in vivo telomere elongation assay where telomerase repeat addition can be monitored over 48 hours. Several analytical procedures for the quantification of telomerase activity, methods for detecting telomerase activity, as well as for identifying compounds that regulate or affect telomerase activity has been reported. However, these methods are time consuming, labor intensive, PCR dependent and susceptible to inhibition by extracts of clinical samples and are difficult to quantify telomerase activity and are subject to false positives. This invention could provide the following advantages:

•Provide insights into telomere length homeostasis.
•Identify potential targets for future therapeutics.
•Identify genes required for telomerase-dependent telomere elongation by measuring de novo telomere addition at a single chromosome over just one cell cycle.
•Allow dissection of new pathways of telomere length regulation.
•The 48 hours required for ADDIT assay allows for identification of essential genes for roles in telomere length regulation.

TECHNICAL DETAILS

Johns Hopkins researchers have developed a de novo telomere elongation assay in mouse cells and with this assay demonstrated that ATM kinase pathway regulates the elongation of telomeres by telomerase. The ADDIT assay was designed in mouse CASTEiJ cells that have telomere length and distribution very similar to humans. This allows functional probing of telomeres in a setting similar to human telomere length regulation.

Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
Activation of ATM kinase pathway elongates telomeres PCT: Patent Cooperation Treaty United States 15/557,393 9/11/2017     Pending
Inventors:
Category(s):
For Information, Contact:
Jeanine Pennington
jpennin5@jhmi.edu
410-614-0300
Save This Technology:
2017 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum